Trigger Point Pain, Myofascial
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
MTIUT - Salt Lake City
1 programextracorporeal shock wave and conventional treamentN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
MTIextracorporeal shock wave and conventional treament
Young BioPharmaPositional release therapy
Clinical Trials (2)
Total enrollment: 120 patients across 2 trials
Myoelectric Activity of Upper Trapezius Trigger Point
Start: Feb 2020Est. completion: Apr 202160 patients
N/ACompleted
Positional Release Therapy and Therapeutic Massage Reduce Muscle Trigger and Tender Points
Start: Dec 2017Est. completion: Feb 201860 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.